Luca Massacesi

Full Professor of Neurology

Università degli Studi di Napoli Federico II

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Luca Massacesi is a Full Professor of Neurology at Università degli Studi di Firenze, Italy. His research focuses on the prediction of seizure recurrence risk, anti-SARS-CoV-2 vaccination effects, and the clinical outcomes of treatments for multiple sclerosis. He has contributed significantly to studies on the incidence of malignant neoplasms in patients with multiple sclerosis and the use of machine learning in clinical predictions.

Articles (8)

Year:

2025

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (1)

Antonio Farina

Université Claude Bernard Lyon 1

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Luca Massacesi

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

A proposal for a machine-learning algorithm for the prediction of seizure recurrence risk at 2 years after discontinuation of anti-seizure medications

Leptomeningeal Gadolinium Enhancement in Autoimmune GFAP Astrocytopathy

Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance

Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: A population-based study on Tuscan residents

Response: Brightening the crystal ball: A constructive reappraisal of the postwithdrawal seizure relapse prediction model

Prediction of seizure recurrence risk following discontinuation of antiepileptic drugs

Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis

Sustained disease remission after discontinuation of disease modifying treatments in relapsing-remitting multiple sclerosis

Collaborators (1)

Antonio Farina

Make your next move.